Plain-English translation of NCT05405673 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Colorectal Cancer research guide โResearchers are testing a new stool-based test that looks for specific bacteria markers to detect colorectal polyps and cancer. Right now, standard stool tests like FIT miss many polyps โ especially early ones. This study wants to see if the M3 bacterial marker panel, combined with other microbial markers, can catch more problems than current tests.
Current stool screening tests miss 40% of advanced polyps and up to 90% of smaller polyps that could turn into cancer. Finding a more accurate non-invasive test could help doctors catch colorectal cancer earlier, when it's easier to treat and prevent.
You will provide a stool sample before undergoing your scheduled colonoscopy. The study compares your stool sample results with what your colonoscopy shows, to see how accurate the bacterial markers are at detecting polyps and cancer. No medication or additional procedures beyond your routine colonoscopy are involved โ just the stool sample collection.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
Hong Kong
Collaborators
Dr Cipto Mangunkusumo General Hospital, Aster CMI Hospital
Enrollment target
~2,500 participants
Started
June 2022
Primary completion
May 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.